Phase I/II Study of Gemcitabine and Exisulind as Second-Line Therapy in Patients with Advanced Non–small Cell Lung Cancer

Autor: Hoang, Tien, Kim, KyungMann, Merchant, Joseph, Traynor, Anne M., McGovern, James, Oettel, Kurt R., Sanchez, Fredrico A., Ahuja, Harish G., Hensing, Thomas A., Larson, Martha, Schiller, Joan H.
Zdroj: In Journal of Thoracic Oncology March 2006 1(3):218-225
Databáze: ScienceDirect